Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis

RA McIvor; AR Rachlis; P Berger; LR Lee Pack; Charles K Chan

doi:10.1155/1995/948507

Canadian Respiratory Journal (Jan 1995)

Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis

RA McIvor,
AR Rachlis,
P Berger,
LR Lee Pack,
Charles K Chan

Affiliations

RA McIvor: Department of Medicine, The Wellesley and Sunnybrook Hospitals, University of Toronto, and The Toronto Central Aerosol Pentamidine Clinic, Toronto, Ontario, Canada
AR Rachlis: Department of Medicine, The Wellesley and Sunnybrook Hospitals, University of Toronto, and The Toronto Central Aerosol Pentamidine Clinic, Toronto, Ontario, Canada
P Berger: Department of Medicine, The Wellesley and Sunnybrook Hospitals, University of Toronto, and The Toronto Central Aerosol Pentamidine Clinic, Toronto, Ontario, Canada
LR Lee Pack: Department of Medicine, The Wellesley and Sunnybrook Hospitals, University of Toronto, and The Toronto Central Aerosol Pentamidine Clinic, Toronto, Ontario, Canada
Charles K Chan: Department of Medicine, The Wellesley and Sunnybrook Hospitals, University of Toronto, and The Toronto Central Aerosol Pentamidine Clinic, Toronto, Ontario, Canada

DOI: https://doi.org/10.1155/1995/948507
Journal volume & issue: Vol. 2, no. 1
pp. 49 – 54

Abstract

Read online

OBJECTIVE: To identify baseline characteristics of human immunodeficiency virus (HIV)-infected individuals on aerosol pentamidine for Pneumocystis carinii prophylaxis that are predictive of subsequent breakthrough Pneumocystis carinii pneumonia (PCP).

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://www.hindawi.com/journals/crj/

About the journal